Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 1
2006 1
2007 1
2008 5
2009 5
2010 6
2011 5
2012 3
2013 4
2015 1
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immunology.
Finn OJ. Finn OJ. N Engl J Med. 2008 Jun 19;358(25):2704-15. doi: 10.1056/NEJMra072739. N Engl J Med. 2008. PMID: 18565863 Review. No abstract available.
Cancer vaccines: accomplishments and challenges.
Pejawar-Gaddy S, Finn OJ. Pejawar-Gaddy S, et al. Crit Rev Oncol Hematol. 2008 Aug;67(2):93-102. doi: 10.1016/j.critrevonc.2008.02.010. Epub 2008 Apr 8. Crit Rev Oncol Hematol. 2008. PMID: 18400507 Review.
Dendritic cells and the maintenance of self-tolerance.
Morel PA, Turner MS. Morel PA, et al. Immunol Res. 2011 Aug;50(2-3):124-9. doi: 10.1007/s12026-011-8217-y. Immunol Res. 2011. PMID: 21717078 Review.
Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells.
Macatangay BJ, Riddler SA, Wheeler ND, Spindler J, Lawani M, Hong F, Buffo MJ, Whiteside TL, Kearney MF, Mellors JW, Rinaldo CR. Macatangay BJ, et al. J Infect Dis. 2016 May 1;213(9):1400-9. doi: 10.1093/infdis/jiv582. Epub 2015 Dec 8. J Infect Dis. 2016. PMID: 26647281 Free PMC article. Clinical Trial.
Epidemiologic perspective on immune-surveillance in cancer.
Cramer DW, Finn OJ. Cramer DW, et al. Curr Opin Immunol. 2011 Apr;23(2):265-71. doi: 10.1016/j.coi.2011.01.002. Epub 2011 Feb 1. Curr Opin Immunol. 2011. PMID: 21277761 Free PMC article. Review.
Dendritic cell immunotherapy for autoimmune diabetes.
Feili-Hariri M, Flores RR, Vasquez AC, Morel PA. Feili-Hariri M, et al. Immunol Res. 2006;36(1-3):167-73. doi: 10.1385/IR:36:1:167. Immunol Res. 2006. PMID: 17337777 Review.
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.
Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, Innocenti GM, Cudic M, Ham JD, Cheung WC, Polakiewicz RD, Finn OJ. Lohmueller JJ, et al. Sci Rep. 2016 Aug 22;6:31740. doi: 10.1038/srep31740. Sci Rep. 2016. PMID: 27545199 Free PMC article.
Dendritic cells, T cell tolerance and therapy of adverse immune reactions.
Morel PA, Feili-Hariri M, Coates PT, Thomson AW. Morel PA, et al. Clin Exp Immunol. 2003 Jul;133(1):1-10. doi: 10.1046/j.1365-2249.2003.02161.x. Clin Exp Immunol. 2003. PMID: 12823271 Free PMC article. Review.
Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation.
Keyel PA, Roth R, Yokoyama WM, Heuser JE, Salter RD. Keyel PA, et al. Toxins (Basel). 2013 Jun 6;5(6):1105-18. doi: 10.3390/toxins5061105. Toxins (Basel). 2013. PMID: 23744055 Free PMC article.
35 results
Jump to page
Feedback